Regencell Bioscience Holdings Limited
RGC
Rangering i aksjer
#3456
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in... Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Aksjekurs
$9.91
Markedsverdi
$4.91B
Endring (1 dag)
-8.24%
Endring (1 år)
-37.08%
Land
HK
Handel Regencell Bioscience Holdings Limited (RGC)
Kategori
Healthcare
Aksjeprishistorikk for Regencell Bioscience Holdings Limited (RGC)
Høyeste sluttskurs: $8.35 den 2026-10-01
Laveste sluttskurs: $0.24 den 2021-07-01
Laveste sluttskurs: $0.24 den 2021-07-01
Aksjeprishistorikk for Regencell Bioscience Holdings Limited fra 2021 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2026 (TTM) | -1.78% |
| 2025 | 13,046.47% |
| 2024 | -47.20% |
| 2023 | -66.01% |
| 2022 | 8.50% |
| 2021 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
